본문 바로가기
KERD
논문KCI 등재

Noroviruses: Recent Updates

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류소아과학

초록

Noroviruses (NoVs) are one major etiologic agent in acute gastroenteritis (AGE) in all ages and are the primary cause of food-borne gastroenteritis worldwide. GII-4 NoVs has predominated since 1990s, and novel recombinant strains have been reported worldwide. Researchers face difficulties in making vaccines and therapeutic agents against NoVs due to the lack of cell culture and animal-model systems and the rapid emergence of novel variant strains. Recently, a randomized clinical trial for intranasal NoVs vaccine has been reported, which casts a light in the way of vaccine production. This review discusses the recent findings on the structure, immunity, and vaccination of NoVs.

Abstract

Noroviruses (NoVs) are one major etiologic agent in acute gastroenteritis (AGE) in all ages and are the primary cause of food-borne gastroenteritis worldwide. GII-4 NoVs has predominated since 1990s, and novel recombinant strains have been reported worldwide. Researchers face difficulties in making vaccines and therapeutic agents against NoVs due to the lack of cell culture and animal-model systems and the rapid emergence of novel variant strains. Recently, a randomized clinical trial for intranasal NoVs vaccine has been reported, which casts a light in the way of vaccine production. This review discusses the recent findings on the structure, immunity, and vaccination of NoVs.

참고문헌 (65)

  1. Lee MB, "A review of enteric outbreaks in child care centers: effective infection control recommendations", Epidemiol Infect, 71, pp.24~32 (2008)
  2. Glass RI, "Norovirus gastroenteritis", N Engl J Med, 361, pp.1776~1785 (2009)
  3. Mattison K, "Norovirus as a foodborne disease hazard", Adv Food Nutr Res, 62, pp.1~39 (2011)
  4. Patel MM, "Systematic literature review of role of noroviruses in sporadic gastroenteritis", Emerg Infect Dis, 14, pp.1224~1231 (2008)
  5. Division of viral diseases, National center for immunization and respiratory diseases, CDC, "Updated norovirus outbreak management and disease prevention guidelines", MMWR Recomm Rep, 4, pp.1~18 (2011)
  6. Ando T, "Genetic classification of “Norwalk-like viruses.”", J Infect Dis, 181, pp.336~348 (2000)
  7. Katayama K, "Phylogenetic analysis of the complete genome of 18 Norwalk-like viruses", Virology, 200, pp.225~239 (2002)
  8. Zheng DP, "Norovirus classification and proposed strain nomenclature", Virology, 346, pp.312~323 (2006)
  9. Donaldson EF, "Norovirus pathogenesis: mechanisms persistence and immune evasion in human population", Immunol Rev, 225, pp.190~211 (2008)
  10. Lindesmith LC, "Mechanism of GII.4 norovirus persistence in human populations", PLoS Med, 5(31) (2008)
  11. Xerry J, "Tracking the transmission routes of genogroup II noroviruses in suspected foodborne or environmental outbreaks of gastroenteritis through sequence analysis of the P2 domain", J Med Virol, 81, pp.1298~1304 (2009)
  12. Green KY, "Taxonomy of the Caliciviruses", J Infect Dis, 181, pp.322~330 (2000)
  13. Jiang X, "Norwalk virus genome cloning and characterization", Science, 250, pp.1580~1583 (1990)
  14. Bok K, "Evolutionary dynamics of GII.4 noroviruses over a 34-year period", J Virol, 83, pp.11890~11901 (2009)
  15. Donaldson EF, "Viral shape-shifting: norovirus evasion of the human immune system", Nat Rev Microbiol, 8, pp.231~241 (2010)
  16. La Rosa G, "Detection of genogroup IV noroviruses in environmental and clinical samples and partial sequencing through rapid amplification of c-DNA ends", Arch Virol, 153, pp.2077~2083 (2008)
  17. Kitajima M, "Seasonal distribution and genetic diversity of genogroups I, II, and IV noroviruses in the Tamagawa River, Japan", Environ Sci Technol, 44, pp.7116~7122 (2010)
  18. Tan M, "Noroviral particle: structure, function and applications in virus-host interaction", Virology, 382, pp.115~123 (2008)
  19. Tan M, "Norovirus-host interaction: multi-selections by human histo-blood group antigens", Trends Microbiol, 19, pp.382~388 (2011)
  20. Tan M, "Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles", Virology, 410, pp.345~352 (2011)
  21. Tan M, "Norovirus P article, a novel platform for vaccine development and antibody production", J Virol, 85, pp.753~764 (2011)
  22. Yamminen K, "A comparison of immunogenicity of norovirus GII-4 virus like particles and P-particles", Immunol, 135, pp.89~99 (2012)
  23. Hogbom M, "The active form of the norovirus RNA-dependent RNA polymerase is a homodimer with cooperative activity", J Gen Virol, 90, pp.281~291 (2009)
  24. Lee N, "Fecal viral concentration and diarrhea in norovirus gastroenteritis", Emerg Infet Dis, 13, pp.1399~1401 (2007)
  25. Sukhrie FH, "Chronic shedders as reservoir for nosocomial transmission of norovirus", J Clin Microbiol, 48, pp.4303~4305 (2010)
  26. Siebenga JJ, "High prevalence of prolonged norovirus shedding and illness among hospitalized patients: a model for in vivo molecular evolution", J Infect Dis, 198, pp.994~1001 (2008)
  27. Shirato H, "Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding", J Virol, 82, pp.10756~10767 (2008)
  28. Boon D, "Comparative evolution of GII-3 and GII-4 norovirus over a 31-year period", J Virol, 85, pp.8656~8666 (2011)
  29. Chan MC, "Covariation of major and minor viral capsid proteins in norovirus genogroup II genotype s strains", J Virol, 86, pp.1227~1232 (2012)
  30. Bok K, "Chimpanzee as an animal model for human norovirus infection and vaccine development", Proc Natl Acad Sci USA, 108, pp.325~330 (2011)
  31. Cheong S, "Enteric viruses in raw vegetables and groundwater used for irrigation in South Korea", Applied and Environmental Microbiology, 75(24), pp.7745~7751, American Society for Microbiology
  32. 유준환, "Epidemiology of Foodborne Norovirus Outbreak in Incheon, Korea", Journal of Korean Medical Science, 25(8), pp.1128~1133 (2010), 대한의학회
  33. Lee JH, "Analysis of foodborne disease outbreaks for improvement of food safety programs in Seoul, Republic of Korea, from 2002 to 2006", J Environ Health, 71, pp.51~55 (2009)
  34. Lee SG, "Nationwide groundwater surveillance of noroviruses in South Korea, 2008", App Environ Microbiol, 77, pp.1466~1474 (2011)
  35. Marshall JA, "The dynamics of norovirus outbreak epidemics: recent insights", Int J Environ Res Public Health, 8, pp.1141~1149 (2011)
  36. Lindesmith LC, "Norovirus GII.4 strain antigenic variation", J Virol, 85, pp.231~242 (2011)
  37. Puustinen L, "Norovirus genotypes in endemic acute gastroenteritis of infants and children in Finland between 1994 and 2007", Epidemiol infect, 140, pp.268~275 (2012)
  38. Han TH, "Emergence of norovirus GII-4", 2008 variant and recombinant strains in Seoul, Korea, 2011, pp.156, 323~329
  39. 박상훈, "Detection of GII-4", 2006b Variant and Recombinant Noroviruses in Children With Acute Gastroenteritis, South Korea, 201001, pp.82, 146~152[DOI]
  40. Yoon JS, "Molecular epidemiology of norovirus infections in children with acute gastroenteritis in South Korea in November 2005 through November 2006", J Clin Microbiol, 46, pp.1474~1477 (2008)
  41. Mathijs E, "Novel norovirus recombinants and of GII.4 sub-lineages associated with outbreaks between 2006 and 2010 in Belgium", Virol J, 8, pp.310~ (2011)
  42. Kaplan JE, "The frequency of a Norwalk-like pattern of illness in outbreaks of acute gastroenteritis", Am J Public Health, 72, pp.1329~1332 (1982)
  43. Huhti L, "Norovirus GII-4 causes a more severe gastroenteritis than other noroviruses in young children", J Infect Dis, 203, pp.1442~1444 (2011)
  44. Roos-Weil D, "Impact of norovirus", sapovirus-related diarrhea in renal transplant recipients hospitalized for diarrhea, 2011, pp.92, 61~69
  45. Schwartz S, "Norovirus gastroenteritis caused severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation", Blood, 117, pp.5850~5856 (2011)
  46. Turcios-Ruiz RM, "Outbreak of necrotizing enterocolitis caused by norovirus in a neonatal intensive care unit", J Pediatr, 153, pp.339~344 (2008)
  47. Stuart RL, "An outbreak of necrotizing enterocolitis associated with norovirus genotype GII.3", Pediatr Infect Dis J, 29, pp.644~647 (2010)
  48. 이지혁, "Norovirus: A Possible Cause of Pneumatosis Intestinalis", JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 52(3), pp.314~318, LIPPINCOTT WILLIAMS & WILKINS
  49. Chen SY, "Norovirus infection as a cause of diarrhea-associated benign infantile seizures", Clin Infect Dis, 48, pp.849~855 (2009)
  50. Chan CM, "Norovirus as cause of benign convulsion associated with gastroenteritis", J Paediatr Child Health, 47, pp.373~377 (2011)
  51. 양혜란, "급성 위장관염에 병발하는 양성 무열성 경련 소아 환자의 대변에서 검출된 바이러스 및 유전자형 분석 연구", Pediatric Gastroenterology, Hepatology & Nutrition, 12(2), pp.183~193 (2009), 대한소아소화기영양학회
  52. Khan RR, "Gastrointestinal norovirus infection associated with exacerbation of inflammatory bowel disease", J Pediatr Gastroenterol Nutr, 48, pp.328~333 (2009)
  53. Cadwell K, "Virus-plus-suceptibility gene interactions determines Crohn’s disease gene Atg16L1 phenotypes in intestine", Cell, 141, pp.1135~1145 (2010)
  54. Straub TM, "In vitro cell culture infectivity assay for human noroviruses", Emerg Infect Dis, 13, pp.396~403 (2007)
  55. Cheetam S, "Pathogenesis of a genogroup II human norovirus in gnobiotic pigs", J Virol, 80, pp.10372~10381 (2006)
  56. Chan MC, "In vitro whole-virus binding of a norovirus genogroup II genotype 4 strain to cells of the lamina propria and Brunner’s glands in the human duodenum", J Virol, 85, pp.8427~8430 (2011)
  57. De Bruin E, "Diagnosis of norovirus outbreaks by commercial ELISA of RT-PCR", J Virol Methods, 137, pp.259~264 (2006)
  58. Kele B, "Comparison of an ELISA and two reverse transcription polymerase chain reaction methods for norovirus detection", Diagn Microbiol Infect Dis, 70, pp.475~478 (2011)
  59. Siddia DM, "Norovirus gastroenteritis successfully treated with nitazoxanide", J Infect, 63, pp.394~397 (2011)
  60. Rossignol JF, "Nitazoxanide in the treatment of viral gastroenteritis: a randomized double-blind placebo-controlled clinical trial", Aliment Pharmacol Ther, 24, pp.1423~1430 (2006)
  61. Dou D, "Inhibition of noroviruses by piperazine derivatives", Bioorg Med Chem Lett, 22, pp.377~379 (2012)
  62. Chang KO, "Interferons and ribavirin effectively inhibit Norwalk virus replication in replicon-bearing cells", J Virol, 22, pp.12111~12118 (2007)
  63. Monroe SS, "Control and prevention of viral gastroenteritis", Emerg Infect Dis, 17, pp.1347~1348 (2011)
  64. Atmar RL, "Norovirus vaccine against experimental human Norwalk virus illness", N Engl J Med, 365, pp.2178~2187 (2011)
  65. Blazevic V, "Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis", Vaccine, 29, pp.8126~8133 (2011)

관련 논문AI추천

이 간행물의 다른 논문 (9건)